Vizgen

Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The companys MERSCOPE Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution. MERSCOPE provides transformative insight into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, infectious disease, developmental biology, cell and gene...

Translational research,single cell genomics,multi-omics,transcriptomics,spatial gene expression ,single cell gene expression,in situ single-cell omics,cell atlases,human cell atlas,spatial genomics research,rna imaging in situ,spatially-resolved rna profiling,high throughput,high resolution,high multiplexing,high accuracy,drug development,immunology,neuroscience,and cancer research

Vizgen operates in the Biotechnology research industry.

Vizgen's revenue is 11m - 100m

Vizgen has 51 - 200 employees.